1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow ST-elevation Myocardial Infarction (STEMI): new trials by email Literature Review of ST-elevation Myocardial Infarction (STEMI) trials Research Report on ST-elevation Myocardial Infarction (STEMI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients empagliflozin, Placebo - ST-elevation Myocardial Infarction (STEMI), Acute Myocardial Infarction (AMI) | Phase 2 | Not yet recruiting | Rehman Medical Institute - RMI | 480 | 2026-09-01 | 2026-08-06 |
| REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction IC Adenosine, IC Sodium nitroprusside (SNP), Standard PCI - ST-elevation Myocardial Infarction (STEMI) | Phase 2 | Completed | University Hospitals, Leicester | 247 | 2011-10-01 | 2015-06-16 |
ST Elevation Myocardial Infarction (2) · Coronary Artery Disease (1) · Myocardial Infarction (1) · Reperfusion Injury (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Infarction (2) · Ischemia (2) · Myocardial Ischemia (2) · Necrosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Coronary Disease (1) · Myocardial Infarction (1) · Postoperative Complications (1)
Nitroprusside (1) · empagliflozin (1)
Rehman Medical Institute - RMI (1) · University Hospitals, Leicester (1)
Pakistan (1) · United Kingdom (1)
Anthony H Gershlick, MBBS, FRCP (1) · Ashraf S Niazi, MBBS, FRCP (1) · Herbert D Aronow, MD, MPH, MSCAI, FACC, MSVM (1) · Miqdad A Khan, MD, FACC, FISCI, FSCAI, FACP (1)